|Articles|September 15, 2002

Clinical setting may not reflect phase III glaucoma trials

Philadelphia-The performance of glaucoma medications in phase III FDA trials may not reflect their performance in a real-world clinical setting, according to researchers at Wills Eye Hospital.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.


Latest CME